Publications

Accepted/In press

2024

Nguemeni Tiako MJ, Knight KR, Schiff DM. Prenatal Opioid Use Disorder Treatment-the Importance of Shared Decision-Making. JAMA Intern Med. Published online January 22, 2024. doi:10.1001/jamainternmed.2023.6976. PMID: 38252420

Mascarenhas M, Wachman EM, Chandra I, Xue R, Sarathy L, Schiff DM. Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome. Pediatrics. Published online January 5, 2024. doi:10.1542/peds.2023-062871. PMID: 38178779

2023

Morrison TM, Schiff DM, Olson A, et al. Hair Cortisol Concentrations in Opioid-Exposed versus Nonexposed Mother-Infant Dyads. Am J Perinatol. Published online December 31, 2023. doi:10.1055/s-0043-1778008. PMID: 38160676

Schiff DM, Muftu S, MacMillan KDL, et al. Mutual Mistrust: The Multilayered Experiences at the Intersection of Healthcare and Early Parenting among Mothers with Opioid Use Disorder [published online ahead of print, 2023 Nov 22]. J Addict Med. 2023;10.1097/ADM.0000000000001242. doi:10.1097/ADM.0000000000001242. PMID: 37994464

Harris M, Schiff DM, Saia K, Muftu S, Standish KR, Wachman EM. Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023). Breastfeed Med. 2023;18(10):715-733. doi:10.1089/bfm.2023.29256.abm. PMID: 37856658

Sternberger L, Sorensen-Alawad A, Prescott T, et al. Lessons Learned Serving Pregnant, Postpartum, and Parenting People with Substance Use Disorders in Massachusetts: The Moms Do Care Program [published online ahead of print, 2023 Oct 4]. Matern Child Health J. 2023;10.1007/s10995-023-03775-5. doi:10.1007/s10995-023-03775-5 PMID: 37792152

Xu KY, Schiff DM, Jones HE, et al. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA [published online ahead of print, 2023 Jul 12]. J Gen Intern Med. 2023;10.1007/s11606-023-08306-0. doi:10.1007/s11606-023-08306-0. PMID: 37436568

Osei-Poku GK, Prentice JC, Peeler M, Bernstein S, Iverson RE, Schiff DM. Risk of Severe Maternal Morbidity in Birthing People With Opioid Use Disorder [published online ahead of print, 2023 Jul 7]. Womens Health Issues. 2023;S1049-3867(23)00119-6. doi:10.1016/j.whi.2023.06.002. PMID: 37423777

Siegel MR, Mahowald GK, Uljon SN, et al. Fentanyl in the labor epidural impacts the results of intrapartum and postpartum maternal and neonatal toxicology tests. Am J Obstet Gynecol. 2023;228(6):741.e1-741.e7. doi:10.1016/j.ajog.2022.11.1293. PMID: 36427599

Morrison TM, Standish KR, Wanar A, et al. Drivers of decision-making regarding infant sleep practices among mothers with opioid use disorder [published online ahead of print, 2023 Jun 3]. J Perinatol. 2023;10.1038/s41372-023-01701-9. doi:10.1038/s41372-023-01701-9. PMID: 37270538

Work EC, Muftu S, MacMillan KDL, et al. Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder [published online ahead of print, 2023 May 31]. Matern Child Health J. 2023;1-9. doi:10.1007/s10995-023-03672-x. PMID: 37253899

Standish KR, Morrison TM, Wanar A, et al. Breastfeeding Decision-Making Among Mothers with Opioid Use Disorder: A Qualitative Study. Breastfeed Med. 2023;18(5):347-355. doi:10.1089/bfm.2022.0226. PMID: 37115582

Wanar A, Morrison TM, Standish KR, et al. Understanding cigarette smoking among mothers with opioid use disorder [published online ahead of print, 2023 May 6]. J Subst Use Addict Treat. 2023;150:209065. doi:10.1016/j.josat.2023.209065. PMID: 37156425

Cohen S, Nielsen T, Chou JH, et al. Disparities in Maternal-Infant Drug Testing, Social Work Assessment, and Custody at 5 Hospitals [published online ahead of print, 2023 Feb 7]. Acad Pediatr. 2023;S1876-2859(23)00014-1. doi:10.1016/j.acap.2023.01.012. PMID: 36754165.

Sarathy L, Chou JH, Lerou PH, et al. Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use. Hosp Pediatr. 2023;13(4):317-325. doi:10.1542/hpeds.2022-006897. PMID: 36855896.

Xu KY, Jones HE, Schiff DM, et al. Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People. Obstet Gynecol. 2023;141(4):845-853. doi:10.1097/AOG.0000000000005117. PMID: 36897142.

Siegel MR, Cohen SJ, Koenigs K, et al. Assessing the Clinical Utility of Toxicology Testing in the Peripartum Period [published online ahead of print, 2023 Apr 6]. Am J Obstet Gynecol MFM. 2023;100963. doi:10.1016/j.ajogmf.2023.100963/ PMID: 37030508.

2022

Schiff DM, Work EC, Muftu S, Partridge S, MacMillan KDL, Gray JR, Hoeppner BB, Kelly JF, Greenfield SF, Jones HE, Wilens TE, Terplan M, Bernstein J. “You have to take this medication, but then you get punished for taking it:” lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. J Subst Abuse Treat. 2022 Mar 18; 108765. PMID: 35341614.

Schiff DM, Work EC, Foley B, Applewhite R, Diop H, Goullaud L, Gupta M, Hoeppner BB, Peacock-Chambers E, Vilsaint CL, Bernstein JA, Bryant AS. Perinatal Opioid Use Disorder Research, Race, and Racism: A Scoping Review. Pediatrics. 2022 Mar 01; 149(3). PMID: 35156121.

Schiff DM, Stoltman JJK, Nielsen TC, Myers S, Nolan M, Terplan M, Patrick SW, Wilens TE, Kelly J. Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder. J Addict Med. 2022 Jan-Feb 01; 16(1):77-83. PMID: 33758119.

Schiff DM, Partridge S, Gummadi NH, Gray JR, Stulac S, Costello E, Wachman EM, Jones HE, Greenfield SF, Taveras EM, Bernstein JA. Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Acad Pediatr. 2022 Jan-Feb;22(1):125-136. doi: 10.1016/j.acap.2021.04.016. Epub 2021 Apr 24. PMID: 33901729.

Schiff DM, Halvorson AE, Dupont W, Davis MM, Patrick SW. Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study. Subst Abus. 2022; 43(1):551-555. PMID: 34586979.

Koenigs KJ, Chou JH, Cohen S, Nolan M, Liu G, Terplan M, Cummings BM, Nielsen T, Smith NA, Distefano J, Bernstein SN, Schiff DM. Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort. Am J Obstet Gynecol MFM. 2022 Jul;4(4):100621. doi: 10.1016/j.ajogmf.2022.100621. Epub 2022 Mar 27. PMID: 35354087.

Reddy J, Schiff D. A response to ‘Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments’. Addiction. 2022 Mar; 117(3):833-834. PMID: 34338392.

Morrison TM, MacMillan KDL, Melvin P, Singh R, Murzycki J, Van Vleet MW, Rothstein R, O’Shea TF, Gupta M, Schiff DM, Wachman EM. Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy. Hosp Pediatr. 2022 May 1;12(5):530-538. doi: 10.1542/hpeds.2021-006301. PMID: 35403199.

Siegel, M. R., Mahowald, G. K., Uljon, S. N., James, K., Leffert, L., Sullivan, M. W., Hernandez, S. J., Gray, J. R., Schiff, D. M., & Bernstein, S. N. Fentanyl in the Labor Epidural Impacts the Results of Intrapartum and Postpartum Maternal and Neonatal Toxicology Tests. American journal of obstetrics and gynecology, 2022; S0002-9378(22)02185-8. PMID: 36427599.

2021

Bernstein SN, Peckham AM, Schiff DM, Gray JR. Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women. Obstet Gynecol. 2021 Feb 1;137(2):377-378. doi: 10.1097/AOG.0000000000004270. PMID: 33481516.

Schiff DM. Dropped. Acad Pediatr. 2021 Mar;21(2):194-195. doi: 10.1016/j.acap.2020.04.001. Epub 2020 Apr 10. PMID: 32283264.

Peacock-Chambers E, Schiff DM, Zuckerman B. Caring for Families with Young Children Affected by Substance Use Disorder: Needed Changes. J Dev Behav Pediatr. 2021 Jun-Jul 01;42(5):408-410. doi: 10.1097/DBP.0000000000000942. PMID: 33883526.

Harris M, Joseph K, Hoeppner B, Wachman EM, Gray JR, Saia K, Wakeman S, Bair-Merritt MH, Schiff DM. A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2021 Jul-Aug 01;15(4):311-317. doi: 10.1097/ADM.0000000000000761. PMID: 33060464.

Raffi ER, Gray J, Conteh N, Kane M, Cohen LS, Schiff DM. Low barrier perinatal psychiatric care for patients with substance use disorder: meeting patients across the perinatal continuum where they are. Int Rev Psychiatry. 2021 Sep;33(6):543-552. doi: 10.1080/09540261.2021.1898351. Epub 2021 Aug 18. PMID: 34406106.

Schiff DM, Nielsen TC, Hoeppner BB, Terplan M, Hadland SE, Bernson D, Greenfield SF, Bernstein J, Bharel M, Reddy J, Taveras EM, Kelly JF, Wilens TE. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Am J Obstet Gynecol. 2021 Oct;225(4):424.e1-424.e12. doi: 10.1016/j.ajog.2021.04.210. Epub 2021 Apr 15. PMID: 33845029.

Schiff DM, Halvorson AE, Dupont W, Davis MM, Patrick SW. Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study. Subst Abus. 2022;43(1):551-555. doi:10.1080/08897077.2021.1975866. PMID: 34586979.

Schiff DM, Partridge S, Gummadi NH, et al. Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Acad Pediatr. 2022;22(1):125-136. doi:10.1016/j.acap.2021.04.016. PMID: 33901729.

2020

Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, Bharel M, Diop H, Taveras EM, Wilens TE, Schiff DM. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery. Addiction. 2020 Feb;115(2):291-301. doi: 10.1111/add.14825. Epub 2019 Nov 13. PMID: 31692133.

Peeler M, Gupta M, Melvin P, Bryant AS, Diop H, Iverson R, Callaghan K, Wachman EM, Singh R, Houghton M, Greenfield SF, Schiff DM. Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019). Am J Public Health. 2020 Dec;110(12):1828-1836. doi: 10.2105/AJPH.2020.305888. Epub 2020 Oct 15. PMID: 33058701.

Schiff DM, Nielsen T, Terplan M, Wakeman SE, Yule AM, Mehta PK, Taveras EM, Wilens TE. IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH. Addiction. 2020 Sep;115(9):1787-1788. doi: 10.1111/add.15041. Epub 2020 Mar 24. PMID: 32143238.

Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, Diop H, Bharel M, Krans EE, Selk S, Kelly JF, Wilens TE, Taveras EM. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts. JAMA Netw Open. 2020 May 1;3(5):e205734. doi: 10.1001/jamanetworkopen.2020.5734. PMID: 32453384.

Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials. 2020 Jun;93:106014. doi: 10.1016/j.cct.2020.106014. Epub 2020 Apr 27. PMID: 32353544.

2019

Schiff DM, Grossman MR. Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant. Semin Fetal Neonatal Med. 2019 Apr;24(2):115-120. doi: 10.1016/j.siny.2019.01.003. Epub 2019 Jan 28. PMID: 30738754.

2018

Schiff DM, Patrick SW, Terplan M. Maternal Health in the United States. N Engl J Med. 2018 Feb 8;378(6):587. doi: 10.1056/NEJMc1715957. PMID: 29419278.

Wachman EM, Schiff DM, Silverstein M. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Apr 3;319(13):1362-1374. doi: 10.1001/jama.2018.2640. PMID: 29614184.

Schiff DM, Wachman EM, Philipp B, Joseph K, Shrestha H, Taveras EM, Parker MGK. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads. Breastfeed Med. 2018 May;13(4):266-274. doi: 10.1089/bfm.2017.0172. Epub 2018 Apr 9. PMID: 29630387.

Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, LaRochelle M, Walley AY, Land T. Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts. Obstet Gynecol. 2018 Aug;132(2):466-474. doi: 10.1097/AOG.0000000000002734. PMID: 29995730.

Wakeman SE, Schiff DM, Gray J. Stigmatizing Language About Neonatal Abstinence Syndrome. JAMA. 2018 Aug 21;320(7):722. doi: 10.1001/jama.2018.7808. PMID: 30140867.

Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, Saia K, Nikita F, Khattab A, Nolin A, Alvarez C, Barry K, Combs G, Stickney D, Driscoll J, Humphreys R, Burke J, Farrell C, Shrestha H, Whalen BL. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018 Aug;38(8):1114-1122. doi: 10.1038/s41372-018-0109-8. Epub 2018 May 8. PMID: 29740196.

Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. Drug Alcohol Depend. 2018 Nov 1;192:45-50. doi: 10.1016/j.drugalcdep.2018.07.024. Epub 2018 Sep 1. PMID: 30205307.

Howard MB, Wachman E, Levesque EM, Schiff DM, Kistin CJ, Parker MG. The Joys and Frustrations of Breastfeeding and Rooming-In Among Mothers With Opioid Use Disorder: A Qualitative Study. Hosp Pediatr. 2018 Dec;8(12):761-768. doi: 10.1542/hpeds.2018-0116. Epub 2018 Nov 6. PMID: 30401783.

2017

Howard MB, Schiff DM, Penwill N, Si W, Rai A, Wolfgang T, Moses JM, Wachman EM. Impact of Parental Presence at Infants’ Bedside on Neonatal Abstinence Syndrome. Hosp Pediatr. 2017 Feb;7(2):63-69. doi: 10.1542/hpeds.2016-0147. PMID: 28137920.

Patrick SW, Schiff DM; COMMITTEE ON SUBSTANCE USE AND PREVENTION. A Public Health Response to Opioid Use in Pregnancy. Pediatrics. 2017 Mar;139(3):e20164070. doi: 10.1542/peds.2016-4070. Epub 2017 Feb 20. PMID: 28219965.

Schiff DM, Drainoni M-L, Rosenbloom D. Addiction Treatment Referral through Local Police. N Engl J Med. 2017 Mar 9;376(10):999. doi: 10.1056/NEJMc1700537. PMID: 28273014.

Schiff DM, Patrick SW. Treatment of Opioid Use Disorder During Pregnancy and Cases of Neonatal Abstinence Syndrome. JAMA Pediatr. 2017 Jul 1;171(7):707. doi: 10.1001/jamapediatrics.2017.0854. PMID: 28459976.

Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D. A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants’ experiences. J Subst Abuse Treat. 2017 Nov;82:41-47. doi: 10.1016/j.jsat.2017.09.003. Epub 2017 Sep 9. PMID: 29021114.

Schiff DM, Zuckerman B, Hutton E, Genatossio C, Michelson C, Bair-Merritt M. Development and Pilot Implementation of a Trauma-Informed Care Curriculum for Pediatric Residents. Acad Pediatr. 2017 Sep-Oct;17(7):794-796. doi: 10.1016/j.acap.2017.03.011. Epub 2017 Mar 28. PMID: 28359836.

Schiff DM, Zuckerman B, Wachman EM, Bair-Merritt M. Trainees’ knowledge, attitudes, and practices towards caring for the substance-exposed mother-infant dyad. Subst Abus. 2017 Oct-Dec;38(4):414-421. doi: 10.1080/08897077.2017.1356423. Epub 2017 Jul 17. PMID: 28715290.

2016

Wachman EM, Schiff DM. Bringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome. Transl Pediatr. 2016 Jan;5(1):12-5. doi: 10.3978/j.issn.2224-4336.2015.12.03. PMID: 26835401.

Schiff DM, Drainoni ML, Bair-Merritt M, Weinstein Z, Rosenbloom D. A Police-Led Addiction Treatment Referral Program in Massachusetts. N Engl J Med. 2016 Dec 22;375(25):2502-2503. doi: 10.1056/NEJMc1611640. PMID: 28002701.